Unlike other gut tests that only examine microbial DNA using metagenomics, Viome's technology evaluates functional expressed genes to determine the impact of various microbial communities on a person's unique gut ecosystem
Key Preclinical Study (Neelakantan et al., 2018): Treatment in diet-induced obese mice produced progressive body weight loss, reduced white adipose tissue mass and adipocyte size, decreased total cholesterol, and no changes in food intake effects were metabolic, not appetite-driven
Wegovy can also increase the risk of acute pancreatitis, gallbladder problems, low blood sugar, kidney problems, increased heart rate, diabetic eye complications, and suicidal ideation
The results it produces are unlike anything seen from earlier medications in its class, and understanding how it works helps you set accurate expectations before starting